Company profile
Adverum Biotechnologies
We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss.
- Industry
- Biotechnology Research
- Employees
- 144
- Headquarters
- Redwood City, California
- Founded
- 2012
- LinkedIn followers
- 15,312
- Office locations
- 1
Adverum Biotechnologies company summary
Adverum Biotechnologies is a company in the Biotechnology Research industry, headquartered in Redwood City, California, founded in 2012. On LinkedIn the company has around 144 employees and 15,312 followers. Its listed specialties include Gene Therapy, Biotechnology, Rare Diseases, Ophthalmology, Retina.
What technology does Adverum Biotechnologies use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Adverum Biotechnologies
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. By overcoming the challenges associated with current treatment paradigms for these debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe. A wholly-owned subsidiary of Eli Lilly and Company.
Specialties
Where is Adverum Biotechnologies located?
Adverum Biotechnologies lists 1 location.
Compare companies similar to Adverum Biotechnologies
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Adverum Biotechnologies adverum.com | Biotechnology Research | 144 | 2012 | Redwood City, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Adverum Biotechnologies
What does Adverum Biotechnologies do?
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its novel gene therapy candidate, ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022), as a one-time, IVT injection for patients with neovascular or wet age-related macular degeneration. By overcoming the challenges associated with current treatment paradigms for these debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe. A wholly-owned subsidiary of Eli Lilly and Company.
How many employees does Adverum Biotechnologies have?
Adverum Biotechnologies has around 144 employees on LinkedIn.
Where is Adverum Biotechnologies headquartered?
Adverum Biotechnologies is headquartered in Redwood City, California.
When was Adverum Biotechnologies founded?
Adverum Biotechnologies was founded in 2012.
Build a lead list from companies like Adverum Biotechnologies
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.